Evaluation of hepatic perfusion and function with modified hepatobiliary scintigraphy

Computerized Medical Imaging and Graphics

Volumn 33, Issue 3, 2009, Pages 182-186

  Cheng, Mu Hua ^a   Pan, Zhi Heng ^a   Ling, Yun Biao ^a   Zhang, Feng ^a   Xu, Jie Hua ^a   Zhang, Yong ^a   Huang, Yao Xiong ^b  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Hepatic cirrhosis; Hepatobiliary scintigraphy; Hepatocellular function; Portal vein pressure

Indexed keywords

BLOOD FLOWS; COMPARTMENT MODELS; DESCENT SPEED; HEALTHY CONTROLS; HEPATIC CIRRHOSIS; HEPATOBILIARY SCINTIGRAPHY; HEPATOCELLULAR FUNCTION; IMINODIACETIC ACIDS; IN CONTROLS; PORTAL VEIN PRESSURE; TWO-COMPARTMENT MODELS;

BLOOD; ETHYLENE; HEMODYNAMICS; INDICATORS (INSTRUMENTS); PHOTOTRANSISTORS; TECHNETIUM;

FUNCTION EVALUATION;

ETIFENIN TC 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; HEPATOBILIARY SCINTISCANNING; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER PERFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RADIOACTIVITY; VEIN BYPASS;

ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMINO ACIDS; LINEAR MODELS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PORTAL PRESSURE; PORTAL VEIN; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 60649108393     PISSN: 08956111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compmedimag.2008.11.005     Document Type: Article

References (22)

1. Sargent S. Management of patients with advanced liver cirrhosis. Nurs Stand 21 (2006) 48-56
2. Herold C., Ganslmayer M., Ocker M., Zopf S., Gailer B., Hahn E.G., et al. Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve. J Gastroenterol Hepatol 18 (2003) 445-449
3. Dib N., Konate A., Oberti F., and Cales P. Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices. Gastroenterol Clin Biol 29 (2005) 975-987
4. Nishiguchi S., Shiomi S., Kurooka H., Iwata Y., Sasaki N., Tamori A., et al. Portal hemodynamics in primary biliary cirrhosis as evaluated by per-rectal portal scintigraphy with Tc-99m pertechnetate. Hepatogastroenterology 50 (2003) 1535-1538
5. Leveson S.H., Wiggins P.A., Giles G.R., Parkin A., and Robinson P.J. Deranged liver blood flow patients in the detection of liver metastases. Br J Surg 72 (1985) 128-130
6. Yu W.K., Chow P.K., Somanesan S., Ng T.H., Sundram F.X., Chan S.T., et al. A non-invasive isotope dilution technique for quantifying hepatic blood flow using radiolabeled red blood cells. Nucl Med Commun 21 (2000) 269-276
7. Tsuneyama K., Ohba K., Zen Y., Sato Y., Niwa H., Minato H., et al. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 43 (2003) 55-61
8. Giannini E.G., Testa R., and Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 172 (2005) 367-379
9. Pratt D.S., and Kaplan M.M. Evaluation of abnormal liver enzyme results in a symptomatic patients. N Engl J Med 342 (2000) 1266-1271
10. Kew M.C. Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 355 (2000) 591-592
11. Al Joudi F.S., and Wahab N.A. The utilization of an index for serum globulin compensation in diseases associated with decreased serum albumin. Med J Malaysia 59 (2004) 495-501
12. Ciccocioppo R., Candelli M., Di Francesco D., Ciocca F., Taglieri G., Armuzzi A., et al. Study of liver function in healthy elderly subjects using the 13C methacetin breath test. Aliment Pharmacol Ther 17 (2003) 227-277
13. Araikum S., Mdaka T., Esser J.D., and Zuckerman M. Hepatobiliary kinetics of technetium-99m-IDA analogs: quantification by linear systems theory. J Nucl Med 37 (1996) 1323-1330
14. Obradovic V., Artiko V., Radevic B., Dapcevic B., and Petrovic N. Single injection hepatic radionuclide angiography and hepatobiliary scintigraphy in the evaluation of liver transplant function. Nucl Med Rev Cent East Eur 7 (2004) 21-25
15. Gambhir S.S., Hawkins R.A., Huang S.C., Hall T.R., Busuttil R.W., and Phelps M.E. Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy. J Nucl Med 30 (1989) 1507-1518
16. Koruk M., Ozkilic S., Savas M.C., Celen Z., Kadayifci A., and Ozkilic C. Evaluation of hepatic functions and biliary dynamics in patients with liver cirrhosis by quantitative scintigraphy. Hepatogastroenterology 50 (2003) 1803-1805
17. Montano-Loza A., and Meza-Junco J. Pathogenesis of portal hypertension. Rev Invest Clin 57 (2005) 596-607
18. Brown P.H., Juni J.E., and Lieberman D.A. Hepatocyte versus biliary disease: a distinction by deconvolutional analysis of technetium-99m IDA time-activity curves. J Nucl Med 29 (1988) 623-630
19. Zheng R.Q., Wang Q.H., Lu M.D., Xie S.B., Ren J., Su Z.Z., et al. Liver fibrosis in chronic viral hepatitis: an ultrasonographic study. World J Gastroenterol 9 (2003) 2484-2489
20. Moreau R., and Lebrec D. Molecular and structural basis of portal hypertension. Clin Liver Dis 10 (2006) 445-457
21. Duda D., Kretowski M., and Bezy-Wendling J. Texture characterization for hepatic tumor recognition in multiphase CT. Biocy Biomed Eng 26 (2006) 15-24
22. Maier M., Hahn P., Schneider G., and Marzi I. Magnetic resonance imaging (MRI) for non-invasive analysis of hepatic function after hemorrhagic shock in the rat. Eur J Trauma 32 (2006) 449-455